Measuring and locating earthquakes
The instrumental scales used to describe the size of an earthquake began with the Richter magnitude scale in the 1930s. It is a relatively simple measurement of an events amplitude, and its use has become minimal in the 21st century. Seismic waves travel through the Earths interior and can be recorded by seismometers at great distances. The surface wave magnitude was developed in the 1950s as a means to measure remote earthquakes and to improve the accuracy for larger events. The moment magnitude scale not only measures the amplitude of the shock but also takes into account the seismic moment (total rupture area, average slip of the fault, and rigidity of the rock). The Japan Meteorological Agency seismic intensity scale, the Medvedev–Sponheuer–Karnik scale, and the Mercalli intensity scale are based on the observed effects and are related to the intensity of shaking. Seismic waves
Every earthquake produces different types of seismic waves, which travel through rock with different velocities:

Longitudinal P-waves (shock- or pressure waves)
Transverse S-waves (both body waves)
Surface waves – (Rayleigh and Love waves)

Speed of seismic waves
Propagation velocity of the seismic waves through solid rock ranges from approx. 3 km/s (1.9 mi/s) up to 13 km/s (8.1 mi/s), depending on the density and elasticity of the medium. In the Earths interior, the shock- or P-waves travel much faster than the S-waves (approx. relation 1.7:1).
Bennett; he used the term "leucocythemia" to describe this pathological condition.The term "leukemia" was coined by Rudolf Virchow, the renowned German pathologist, in 1856. As a pioneer in the use of the light microscope in pathology, Virchow was the first to describe the abnormal excess of white blood cells in people with the clinical syndrome described by Velpeau and Bennett. As Virchow was uncertain of the etiology of the white blood cell excess, he used the purely descriptive term "leukemia" (Greek: "white blood") to refer to the condition.Further advances in the understanding of AML occurred rapidly with the development of new technology. In 1877, Paul Ehrlich developed a technique of staining blood films which allowed him to describe in detail normal and abnormal white blood cells. Wilhelm Ebstein introduced the term "acute leukemia" in 1889 to differentiate rapidly progressive and fatal leukemias from the more indolent chronic leukemias. The term "myeloid" was coined by Franz Ernst Christian Neumann in 1869, as he was the first to recognize white blood cells were made in the bone marrow (Greek: μυєλός, myelos, lit. (bone) marrow) as opposed to the spleen. The technique of bone marrow examination to diagnose leukemia was first described in 1879 by Mosler. Finally, in 1900, the myeloblast, which is the malignant cell in AML, was characterized by Otto Naegeli, who divided the leukemias into myeloid and lymphocytic.In 2008, AML became the first cancer genome to be fully sequenced. DNA extracted from leukemic cells were compared to unaffected skin.